Individualized Homoeopathy Added to Standard Pharmacological Care for Migraine: A Pragmatic Randomized Open-Label Blinded-Endpoint Controlled Trial

Background

Migraine is the second leading cause of years lived with disability worldwide and the leading cause among young women; daily functioning, rather than attack frequency alone, is now a priority outcome. Individualized homoeopathy is widely used as an adjunct, yet adjunctive pragmatic evidence in tertiary public-sector Indian care is scarce.